Natura

Last updated January 31, 2026

275

Innovation Areas

20,463

Inventors

Collaborations

Aryl dihydronaphthalene lignan scaffolds: NaturaRecent Research Landscape

Low extraction yields and structural instability of bioactive terpenoids increase pharmaceutical production costs. Precise chemical synthesis and isolation of specific benzofuran and phloroglucinol scaffolds ensure consistent therapeutic potency.

What technical problems is Natura addressing in Aryl dihydronaphthalene lignan scaffolds?

Pathological thrombus formation

(40)evidences

Pathological narrowing and structural failure of blood vessels. Mitigating these conditions prevents cardiovascular events and chronic arterial disease.

Insufficient cytotoxic drug selectivity

(22)evidences

The keywords identify various chemical scaffolds specifically targeting cancer treatment. The underlying technical challenge is the failure to arrest the rapid and unregulated growth of tumor cells.